magent
Deterministic published-formula arithmetic plus ICD-10-CM, RxNorm, and LOINC. Pay in USDC on Base via x402.
Mediaofflineeip155:8453Exactvia cdp
GipssMyelofibrosisHematologyPrognosisKaryotype
Calls · 30d
2→ 0%
This endpoint's own trailing-30-day call count, as published by the upstream catalog and snapshotted daily. 13 snapshots so far.
$13.75
Verified settled volume
2,750 settlements proven x402 by their on-chain EIP-3009 marker.
$0.0050
Listed price
As published in the catalog. Always read the live 402 before paying.
2
Calls · 30d
Upstream's own call count for this endpoint, not ours.
1
Unique payers · 30d
Last called 2026-08-31 13:40Z
—
Upstream on-chain volume
Reported by the source catalog.
Paid to
0x836Be278f1739fB4308091cD1852F7971Bc19Ee2The wallet the 402 directs payment to. Its whole payment record — every payer, every chain — is on the merchant page.
Asset 0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913
Provider
The payTo wallet does not resolve to a registered ERC-8004 agent. That is not a verdict on the service — most of the catalog is unregistered.
Live 402 challenge
Captured by the enrichment pass, not read just now. Prices can change — always read the 402 the endpoint answers with.
{
"error": "PAYMENT-SIGNATURE header is required",
"accepts": [
{
"asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
"extra": {
"name": "USD Coin",
"version": "2",
"paymentFlow": "upfront",
"resourceUrl": "https://api.magentlab.com/api/calc/gipss",
"assetTransferMethod": "eip3009"
},
"payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2",
"amount": "5000",
"scheme": "exact",
"network": "eip155:8453",
"maxTimeoutSeconds": 600
},
{
"asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
"extra": {
"name": "USD Coin",
"version": "2",
"withdrawDelay": 86400,
"receiverAuthorizer": "0x3721824a31197dcDD2984cF43b92B6cc8A87c0Fb",
"assetTransferMethod": "eip3009"
},
"payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2",
"amount": "5000",
"scheme": "batch-settlement",
"network": "eip155:8453",
"maxTimeoutSeconds": 600
}
],
"resource": {
"url": "https://api.magentlab.com/api/calc/gipss",
"tags": [
"gipss",
"myelofibrosis",
"hematology",
"prognosis",
"karyotype"
],
"mimeType": "application/json",
"description": "Tefferi 2018 GIPSS for primary myelofibrosis: karyotype (favorable 0, unfavorable 1, VHR 2; caller assigns the three-tier class), absence of type 1/like CALR 1, ASXL1 1, SRSF2 1, U2AF1Q157 1 (not S34); max 6. Low 0, intermediate_1 1, intermediate_2 2, high ≥3. Published median (5-year) survivals 26.4 y (94%), 8.0 y (73%), 4.2 y (40%), 2 y (14%). Not DIPSS or MIPSS70-plus. magent does not karyotype or sequence.",
"serviceName": "magent"
},
"extensions": {
"bazaar": {
"info": {
"input": {
"type": "http",
"method": "GET",
"queryParams": {
"karyotype": "favorable",
"asxl1_mutated": false,
"srsf2_mutated": false,
"calr_type1_like": true,
"u2af1_q157_mutated": false
}
},
"output": {
"type": "json",
"example": {
"score": 0,
"formula": "gipss",
"citation": {
"id": "tefferi-2018",
"doi": "10.1038/s41375-018-0107-z",
"pmid": "29654267",
"title": "GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis",
"source": "Leukemia. 2018;32(7):1631-1642",
"authors": "Tefferi A, Guglielmelli P, Nicolosi M, Mannelli F, Mudireddy M, Bartalucci N, Finke CM, Lasho TL, Hanson CA, Ketterling RP, Begna KH, Gangat N, Pardanani A, Vannucchi AM"
},
"karyotype": "favorable",
"max_score": 6,
"components": [
{
"value": "favorable",
"factor": "karyotype",
"points": 0,
"present": false
},
{
"factor": "absence_of_calr_type1_like",
"points": 0,
"present": false
},
{
"factor": "asxl1_mutated",
"points": 0,
"present": false
},
{
"factor": "srsf2_mutated",
"points": 0,
"present": false
},
{
"factor": "u2af1_q157_mutated",
"points": 0,
"present": false
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"risk_group": "low",
"asxl1_mutated": false,
"srsf2_mutated": false,
"calr_type1_like": true,
"formula_expression": "GIPSS = karyotype (favorable 0, unfavorable 1, vhr 2) + absence of type 1/like CALR 1 + asxl1_mutated 1 + srsf2_mutated 1 + u2af1_q157_mutated 1; Tefferi 2018; max 6; low 0, intermediate_1 1, intermediate_2 2, high ≥3",
"u2af1_q157_mutated": false,
"median_survival_years": 26.4,
"five_year_survival_percent": 94
}
},
"iconUrl": "https://api.magentlab.com/favicon.ico"
},
"schema": {
"type": "object",
"$schema": "https://json-schema.org/draft/2020-12/schema",
"required": [
"input"
],
"properties": {
"input": {
"type": "object",
"required": [
"type",
"method"
],
"properties": {
"type": {
"type": "string",
"const": "http"
},
"method": {
"enum": [
"GET",
"HEAD",
"DELETE"
],
"type": "string"
},
"headers": {
"type": "object",
"additionalProperties": {
"type": "string"
}
},
"queryParams": {
"type": "object",
"required": [
"karyotype",
"calr_type1_like",
"asxl1_mutated",
"srsf2_mutated",
"u2af1_q157_mutated"
],
"properties": {
"karyotype": {
"enum": [
"favorable",
"unfavorable",
"vhr"
],
"type": "string",
"description": "Tefferi 2018 revised three-tier karyotype as assigned by the caller (mutually exclusive). favorable is a normal karyotype or sole 13q−, +9, 20q−, chromosome 1 translocation/duplication, or sex chromosome abnormality including −Y and scores 0. unfavorable is all other abnormalities and scores 1. vhr is very high risk: single/multiple −7, i(17q), inv(3)/3q21, 12p−/12p11.2, 11q−/11q23, +21, or other autosomal trisomies not including +8/+9 and scores 2. magent does not karyotype."
},
"asxl1_mutated": {
"type": "boolean",
"description": "ASXL1 mutation as assigned by the caller (Tefferi 2018). true scores 1. magent does not sequence."
},
"srsf2_mutated": {
"type": "boolean",
"description": "SRSF2 mutation as assigned by the caller (Tefferi 2018). true scores 1. magent does not sequence."
},
"calr_type1_like": {
"type": "boolean",
"description": "Presence of a type 1/like CALR mutation as assigned by the caller (Tefferi 2018). false (absence) scores 1. true scores 0. Type 2/like CALR, JAK2, MPL, and triple-negative are absence of type 1/like CALR. magent does not sequence."
},
"u2af1_q157_mutated": {
"type": "boolean",
"description": "U2AF1 Q157 mutation (Q157P or Q157R) as assigned by the caller (Tefferi 2018). true scores 1. U2AF1 S34 does not score. magent does not sequence."
}
}
}
},
"additionalProperties": false
},
"output": {
"type": "object",
"required": [
"type"
],
"properties": {
"type": {
"type": "string"
},
"example": {
"type": "object"
}
}
}
}
}
}
},
"x402Version": 2
}Accepts
The payment requirements as published to the catalog. Read the live 402 before paying — a price here is a claim, not a quote.
0.005USDC≈ $0.005 USD
on Base · exact scheme
Pay 0.005 USDC on Base to 0x836B…19Ee2. The signed payment is good for 10 minutes.
- Paid to
- 0x836B…19Ee2
- USD Coin contract
- 0x8335…02913
- Payment window
- 10 minutes
- As published
- 5000 smallest units
The catalog’s raw entry
[
{
"asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
"extra": {
"name": "USD Coin",
"version": "2",
"paymentFlow": "upfront",
"resourceUrl": "https://api.magentlab.com/api/calc/gipss",
"assetTransferMethod": "eip3009"
},
"payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2",
"amount": "5000",
"scheme": "exact",
"network": "eip155:8453",
"maxTimeoutSeconds": 600
}
]Extensions
{
"bazaar": {
"info": {
"input": {
"body": {
"items": [
{
"karyotype": "favorable",
"asxl1_mutated": false,
"srsf2_mutated": false,
"calr_type1_like": true,
"u2af1_q157_mutated": false
},
{
"karyotype": "favorable",
"asxl1_mutated": false,
"srsf2_mutated": false,
"calr_type1_like": true,
"u2af1_q157_mutated": false
}
]
},
"type": "http",
"method": "POST"
},
"output": {
"type": "json",
"example": {
"path": "/api/calc/gipss",
"count": 2,
"items": [
{
"score": 0,
"formula": "gipss",
"citation": {
"id": "tefferi-2018",
"doi": "10.1038/s41375-018-0107-z",
"pmid": "29654267",
"title": "GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis",
"source": "Leukemia. 2018;32(7):1631-1642",
"authors": "Tefferi A, Guglielmelli P, Nicolosi M, Mannelli F, Mudireddy M, Bartalucci N, Finke CM, Lasho TL, Hanson CA, Ketterling RP, Begna KH, Gangat N, Pardanani A, Vannucchi AM"
},
"karyotype": "favorable",
"max_score": 6,
"components": [
{
"value": "favorable",
"factor": "karyotype",
"points": 0,
"present": false
},
{
"factor": "absence_of_calr_type1_like",
"points": 0,
"present": false
},
{
"factor": "asxl1_mutated",
"points": 0,
"present": false
},
{
"factor": "srsf2_mutated",
"points": 0,
"present": false
},
{
"factor": "u2af1_q157_mutated",
"points": 0,
"present": false
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"risk_group": "low",
"asxl1_mutated": false,
"srsf2_mutated": false,
"calr_type1_like": true,
"formula_expression": "GIPSS = karyotype (favorable 0, unfavorable 1, vhr 2) + absence of type 1/like CALR 1 + asxl1_mutated 1 + srsf2_mutated 1 + u2af1_q157_mutated 1; Tefferi 2018; max 6; low 0, intermediate_1 1, intermediate_2 2, high ≥3",
"u2af1_q157_mutated": false,
"median_survival_years": 26.4,
"five_year_survival_percent": 94
},
{
"score": 0,
"formula": "gipss",
"citation": {
"id": "tefferi-2018",
"doi": "10.1038/s41375-018-0107-z",
"pmid": "29654267",
"title": "GIPSS: genetically inspired prognostic scoring system for primary myelofibrosis",
"source": "Leukemia. 2018;32(7):1631-1642",
"authors": "Tefferi A, Guglielmelli P, Nicolosi M, Mannelli F, Mudireddy M, Bartalucci N, Finke CM, Lasho TL, Hanson CA, Ketterling RP, Begna KH, Gangat N, Pardanani A, Vannucchi AM"
},
"karyotype": "favorable",
"max_score": 6,
"components": [
{
"value": "favorable",
"factor": "karyotype",
"points": 0,
"present": false
},
{
"factor": "absence_of_calr_type1_like",
"points": 0,
"present": false
},
{
"factor": "asxl1_mutated",
"points": 0,
"present": false
},
{
"factor": "srsf2_mutated",
"points": 0,
"present": false
},
{
"factor": "u2af1_q157_mutated",
"points": 0,
"present": false
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"risk_group": "low",
"asxl1_mutated": false,
"srsf2_mutated": false,
"calr_type1_like": true,
"formula_expression": "GIPSS = karyotype (favorable 0, unfavorable 1, vhr 2) + absence of type 1/like CALR 1 + asxl1_mutated 1 + srsf2_mutated 1 + u2af1_q157_mutated 1; Tefferi 2018; max 6; low 0, intermediate_1 1, intermediate_2 2, high ≥3",
"u2af1_q157_mutated": false,
"median_survival_years": 26.4,
"five_year_survival_percent": 94
}
]
}
},
"iconUrl": "https://api.magentlab.com/favicon.ico"
},
"schema": {
"type": "object",
"$schema": "https://json-schema.org/draft/2020-12/schema",
"required": [
"input"
],
"properties": {
"input": {
"type": "object",
"required": [
"type",
"method"
],
"properties": {
"body": {
"type": "object",
"required": [
"items"
],
"properties": {
"items": {
"type": "array",
"items": {
"type": "object",
"required": [
"karyotype",
"calr_type1_like",
"asxl1_mutated",
"srsf2_mutated",
"u2af1_q157_mutated"
],
"properties": {
"karyotype": {
"enum": [
"favorable",
"unfavorable",
"vhr"
],
"type": "string",
"description": "Tefferi 2018 revised three-tier karyotype as assigned by the caller (mutually exclusive). favorable is a normal karyotype or sole 13q−, +9, 20q−, chromosome 1 translocation/duplication, or sex chromosome abnormality including −Y and scores 0. unfavorable is all other abnormalities and scores 1. vhr is very high risk: single/multiple −7, i(17q), inv(3)/3q21, 12p−/12p11.2, 11q−/11q23, +21, or other autosomal trisomies not including +8/+9 and scores 2. magent does not karyotype."
},
"asxl1_mutated": {
"type": "boolean",
"description": "ASXL1 mutation as assigned by the caller (Tefferi 2018). true scores 1. magent does not sequence."
},
"srsf2_mutated": {
"type": "boolean",
"description": "SRSF2 mutation as assigned by the caller (Tefferi 2018). true scores 1. magent does not sequence."
},
"calr_type1_like": {
"type": "boolean",
"description": "Presence of a type 1/like CALR mutation as assigned by the caller (Tefferi 2018). false (absence) scores 1. true scores 0. Type 2/like CALR, JAK2, MPL, and triple-negative are absence of type 1/like CALR. magent does not sequence."
},
"u2af1_q157_mutated": {
"type": "boolean",
"description": "U2AF1 Q157 mutation (Q157P or Q157R) as assigned by the caller (Tefferi 2018). true scores 1. U2AF1 S34 does not score. magent does not sequence."
}
}
},
"maxItems": 25,
"minItems": 1
}
},
"additionalProperties": false
},
"type": {
"type": "string",
"const": "http"
},
"method": {
"type": "string",
"const": "POST"
},
"headers": {
"type": "object",
"additionalProperties": {
"type": "string"
}
}
},
"additionalProperties": false
},
"output": {
"type": "object",
"required": [
"type"
],
"properties": {
"type": {
"type": "string"
},
"example": {
"type": "object"
}
}
}
}
}
}
}Provenance
- Seen in the source catalog
- 2026-08-31 13:40Z
- Last indexed by Roundhouse
- 2026-09-07 06:20Z
- Last enriched (probe, favicon, geo)
- 2026-09-13 07:15Z
- x402 version
- 2
- Max timeout
- 600s
- Liveness probe
- HTTP 0
Hand this page to an agent
Copy the prompt and paste it into Claude, an MCP client or your own agent — it will vet this service and call it over the free read API. No key, no account.
GET api.roundhouseai.io/v0/endpoints
This endpoint's own trailing-30-day call count, as published by the upstream catalog and snapshotted daily. 13 snapshots so far. Verified volume counts only settlements with an on-chain EIP-3009 marker.
Show the promptHide the prompt
Using Roundhouse, look up the x402 service magent and tell me whether it is worth paying: what a call costs, whether the endpoint answered when last probed, and what its payment record actually shows. curl -s 'https://api.roundhouseai.io/v0/endpoints?q=magent' curl -s 'https://api.roundhouseai.io/v0/merchants/<the payTo wallet returned above>' Then call it: read the price from the live 402 at https://api.magentlab.com/api/calc/gipss, never from a cached figure, and pay with an x402 client. The /v0 API needs an API key (`authorization: Bearer rh_live_…`) on everything except /v0/unified* and /v0/endpoints. Mint a personal key for $0.01 at GET https://api.roundhouseai.io/v0/test/x402, or use an organization key from https://roundhouseai.io/dashboard/team. If you do not have Roundhouse tools or skills installed, read https://roundhouseai.io/skill.md first — it is the whole procedure.